One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration

Similar documents
I ntravenous (IV) medication errors have led to considerable

Medication Safety Dashboard

Preventing Adverse Drug Events and Harm

5th International Conference on Well-Being in the Information Society, WIS 2014, Turku, Finland, August 18-20, 2014

Achieving safety in medication management through barcoding technology

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

SHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS

3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance

Smart Pumps and Drug Libraries The Way Forward

IMPACT OF TECHNOLOGY ON MEDICATION SAFETY

Pharmaceutical Services Report to Joint Conference Committee September 2010

Raising the Bar On Infusion Safety: A Patient Safety Program at Baylor Scott & White Health Improving Infusion Pump Safety: A Systematic Approach

OHTAC Recommendation. Implementation and Use of Smart Medication Delivery Systems

Objectives. Key Elements. ICAHN Targeted Focus Areas: Staff Competency and Education Quality Processes and Risk Management 5/20/2014

Constant Pursuit of Medication Safety. Geraldine Koh Chief Pharmacist

Running head: MEDICATION ERRORS 1. Medications Errors and Their Impact on Nurses. Kristi R. Rittenhouse. Kent State University College of Nursing

Automation and Information Technology

COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE)

Case Study from Parallon

Importance of Clinical Leadership in Pharmacy

The Medication Safety Journey Natasha Nicol, Pharm. D., FASHP Director of Medication Safety June 4, 2009

Background and Methodology

Medication Safety Technology The Good, the Bad and the Unintended Consequences

From Big Data to Big Knowledge Optimizing Medication Management

To describe the process for the management of an infusion pump involved in an adverse event or close call.

Assessing Medical Technology- Are We Being Told the Truth. The Case of CPOE. David C Classen M.D., M.S. FCG and University of Utah

Legislating Patient Safety: The California Experience. October 2003

The Impact of CPOE and CDS on the Medication Use Process and Pharmacist Workflow

Streamlining the medication order process

Alaris System. Medication safety system focused at the point of care

Safe Medication Practices

Computerized provider order entry (CPOE) has. Impact of Computerized Provider Order Entry on Hospital Medication Errors. Reports from the field

Objectives. Demographics: Type and Services 1/22/2014. ICAHN Aggregate Results. ISMP Medication Safety Self Assessment for Hospitals

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

electronic Medication Management (emm) Innovation and Systems Research

Session Objectives. Medication Errors in Adults and Children. Dennis Quaid American Society of Health- System Pharmacists (ASHP) Meeting December 2009

Adverse Drug Events and Readmissions: The Global Picture

Objectives MEDICATION SAFETY & TECHNOLOGY. Disclosure. How has technology improved the way we dispense and compound medications AdminRx AcuDose Rx

Intravenous Infusion Practices and Patient Safety: Insights from ECLIPSE

Considerations for Sterile Compounding of Parenteral Products for Pediatric Use: Part 2 PharMEDium Lunch and Learn Series LUNCH AND LEARN

Medication Safety Way Beyond the 5 Rights

Who Cares About Medication Reconciliation? American Pharmacists Association American Society of Health-system Pharmacists The Joint Commission Agency

A Breastmilk Management System Improves Patient Safety

Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003

Ghalib Abbasi, RPh, MS, PharmD Pharmacy Technology Consultant Florida, USA

Introduction. Medication Errors. Objectives. Objectives. January What is a Medication Error? Define medication errors/variances

A23/B23: Patient Harm in US Hospitals: How Much? Objectives

Most of you flew to this meeting

End-to-end infusion safety. Safely manage infusions from order to administration

Maimonides Medical Center Makes a Quantum Leap with Advanced Computerized Patient Record Technology

Introduction of EPMA in paediatric practice in UK:

Practice Spotlight. Children's Hospital Central California Madera, California

Disclosure. Institute of Medicine (IOM) 1,2. Objectives 5/15/2014. Technician Education Day May 24, 2014 Ft. Lauderdale, FL

Guidance for Medication Reconciliation and System Integration Process

To prevent harm to patients from adverse medication events involving high-alert medications.

Session 2 Improving Narcotics and Opiate Management

Electronic Prescribing of Chemotherapy-It s Not a Video Game!

Plum 360 TM Infusion System with Full IV-EHR Interoperability

Leapfrog Group Report on CPOE Evaluation Tool Results June 2008 to January 2010

D DRUG DISTRIBUTION SYSTEMS

Required Organizational Practices Resources for 2016

PHARMACY SERVICES/MEDICATION USE

The Colorado ALTO Project

EMR Adoption: Benefits Realization

Pharmacists in Transitions of Care: We Can All Make a Difference

Best Practices and Performance Measures for Systemic Treatment Computerized Prescriber Order Entry Systems (ST CPOE) in Chemotherapy Delivery

Evaluation of Cart Fill Drug Distribution System for In-patients at a South Indian Tertiary Care Teaching Hospital

Improving Safety Practices Anticoagulation Therapy

Re-Engineering Medication Processes to Capitalize on Technology. Jane Englebright, PhD, RN Vice President, Quality HCA

A Better Prescription for Reducing Medication Errors and Maximizing the Value of Clinical Decision Support

Adverse Drug Events: A Collaborative Approach for Improvement. Mary Kathryn Cone, PGY-2

Medication Management: Is It in Your Toolbox?

Session ID: District4

Reducing Medical Errors at the Bedside

Medication Control and Distribution. Minor/technical revision of existing policy. ± Major revision of existing policy Reaffirmation of existing policy

SPSP Medicines. Prepared by: NHS Ayrshire and Arran

Walking the Tightrope with a Safety Net Blood Transfusion Process FMEA

PGY-1 Pharmacy Practice

How BPOC Reduces Bedside Medication Errors White Paper

Measuring medication safety with smart IV systems

PHARMACY PRACTICE. Residency Program

Improving the Patient Experience Through Pharmacy

Optimizing pharmaceutical care via Health Information Technology:

Minimizing Prescription Writing Errors: Computerized Prescription Order Entry

Bar Code Medication Administration and MAR Resource Manual

Alaris Products. Protecting patients at the point of care

BAR CODE MEDICATION ADMINISTRATION: A STRATEGIC TECHNOLOGY INTERVENTION FOR REDUCING HOSPITAL S MEDICATION ERRORS

Supporting The Joint Commission 2012 Standards and National Patient Safety Goals

Current Status: Active PolicyStat ID:

Administrative Update: How to Implement Discharge Pharmacy Services (DPS) Objectives

Preventing Disasters in Your Practice

Patient Safety and Quality Measures for CRRT: The UAB Experience. Ashita Tolwani, M.D. University of Alabama at Birmingham CRRT 2012

(10+ years since IOM)

Introduction of Closed Loop Medication Management System for Inpatient Services in Singapore

Reconstitution Nursing Dosage Calculation Practice Problems

Drug Events. Adverse R EDUCING MEDICATION ERRORS. Survey Adapted from Information Developed by HealthInsight, 2000.

Implementation of patient safety strategies in European hospitals

IV Interoperability: Smart Pump and BCMA Integration

CareFusion Overview Scott Bostick SVP/GM Pyxis Dispensing Technologies

Transcription:

One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration Presented by: Marla Husch Northwestern Memorial Hospital

Northwestern Memorial Hospital Chicago, Illinois 750-bed tertiary care academic medical center providing a full range of services except pediatrics NMH Strategic Goals Best Patient Experience Best People Exceptional Financial Performance

Northwestern Memorial Hospital: Pharmacy Services Pharmacy services available 7 days/week, 24 hours/day Decentralized pharmacies: 6 satellites Pharmacy prepares all IV infusions except standard IV fluids which are floor-stocked items

What is needed Data to identify common causes of IV administration errors Studies investigating the frequency, cause, and severity of adverse events associated with IV infusion devices Ongoing research around evolving technology: positive and negative effects on IV administration

IV Pump FMEA : Failure Modes and Recommendations Failure Modes Recommendations Error in programming (RPN = 900) Error in initial set-up and handling of pump (RPN = 800) Inadequate patient assessment (RPN = 700) Develop policy and procedure for pump use Universal orientation through the academy Annual nursing competencies for utilizing pumps Surveillance to better understand trends Apply FMEA process to equipment prior to purchase

Goals of a Point of Prevalence Day to Validate the FMEA Team s Assessment of Risks Determine the actual frequency and potential severity of discrepancies associated with infusion pump orders, medications, labels, and programming, which may reflect errors, at Northwestern Memorial Hospital, on a first shift of a high-volume day among virtually all inpatients. Determine the potential impact of smart pumps on IV administration errors

Hypotheses The actual number of errors exceeds the number reported through incident reports IV pump errors are high-risk Programming errors occur frequently and have the potential to cause harm Smart pump technology will mitigate most IV administration errors associated with IV pumps

Methodology Observational approach Data collection criteria: First shift (0800-1700) on a high volume day All IV pumps in use on inpatient care units Exceptions include: Operating room s, Emergency Department, Postpartum, Labor and Delivery, and Recovery

Methodology Bedside: Documented the medication, rate displayed on the infusion pump, and rate documented on the fluid/medication label Medical Record: Compared the information documented at bedside to what was prescribed in the medical record Documented discrepancies and evaluated associated potential harm, using the NCC MERP scale Retrospective Potential impact of smart pump technology without an interface with other systems Three investigators (two nurses and a pharmacist) rated all rate deviation errors as to whether or not smart pump technology would have prevented the error (yes or no)

Error definition Any preventable event that may cause or lead to inappropriate IV medication use via an IV pump or patient harm while the medication is in the control of the healthcare professional, patient or consumer 3 Such events may be related to professional practice, healthcare products, procedures and systems including order communication, product labeling, compounding, dispensing, administration, education, monitoring and use 3 3. National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). NCC MERP Index for Categorizing Medication Errors. Available at http://www.nccmerp.org. Accessed January 20, 2003.

Error types Rate deviation Incorrect IV medication Delay of rate change or medication change No rate documented on label Incorrect rate documented on label Unauthorized medication Patient Identification error

Total census: 669 patients Results Total # patients eligible: 486 Total # patients with pump(s): 286 Total number of medications observed: 426

Results: Discrepancies Medications observed = 426 Observations with no discrepancy = 145 (34%) Observations with 1 or more discrepancies = 281 (66%) 426 Observations 390 Discrepancies 0.92 Discrepancies per observation 1.3 discrepancies per patient with an IV pump

Results: Types of Discrepancies n = 426 Patient identification error 13% Rate deviation 9% Incorrect IV medication 3% Unauthorized medication 16% Delay of therapy 1% Incorrect rate on label 4% No rate on label 46%

NCC MERP Index: Harm Category A B C D E F G H I Definition Capacity to Cause Error Error Did Not Reach Patient Error Reached Patient, No Harm Error Reached Patient, Required Monitoring Temporary Harm Temporary Harm, Prolonged Hospitalization Permanent Harm Intervention Necessary to Sustain Life Death National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). NCC MERP Index for Categorizing Medication Errors. Available at http://www.nccmerp.org. Accessed January 20, 2003

Results: Harm Number, frequency and potential severity of each type of error Type of error Total (n=389) Frequency per medication observations (n=426) * NCC MERP severity rating No rate on label 195 46% 195 Unauthorized medication Patient identification error C D E F 68 16% 65 3 55 13% 55 Rate deviation 37 9% 29 4 1 3 Incorrect rate on label 16 4% 16 Incorrect medication 14 3% 11 2 1 Delay of rate or medication change 4 1% 2 2 Total (%) n=389 373 (96) 8 (2) 5 (1) 3 (1) Note: * Percents in this column do not add to 100 because some medications had more than one error.

Error examples Medication and dose infusing via IV pump Nicardipine 25mg/250mL @ 15mg/hour Medical record order Start Nicardipine now Hydromorphone 0.2mg/mL @ 1 mg every 30 minutes Hydromorphone 2mg every 30 minutes (verbal order never documented in medical record)

Error examples Medication and dose infusing via IV pump Medical record order Hydromorphone 1mg/mL @ 2mg every 15 minutes prn No new order upon transfer to ICU in medical record Amiodarone 0.5mg/minute Hydromorphone 1mg/mL @ 0.5mg every 15 minutes prn Order written 5 days prior: Amiodarone 1mg/min x 6 hours then 0.5mg/min x 18 hours Hydromorphone 0.2mg/mL @ 1 mg every 15minutes

Error examples Medication and dose infusing via IV pump Medical record order Heparin 200units/hour (2mL/hour) Heparin 1300units/hour (13mL/hour) Dopamine 800mg/250mL @ 2 mcg/kg/hour Dopamine 200mg/250mL @ 2mcg/kg/hour 0.9 normal saline @ 20mL/hour 0.9 normal saline @ 250mL/hour

Risk Data and Prevalence Day Data Programming and wrong medication discrepancies Risk Data 48 discrepancies reported over 2 years on 1st shift Prevalence Day Data 55 discrepancies observed in one day (January 29, 2003) on 1st shift

Study Limitations It is possible that the number of IV administration pump errors that occurred on the day that data was collected was different than other days Because most of the errors were intercepted by research team members the potential harm of the error if it had continued indefinitely was estimated based on our best clinical judgment The likelihood that smart pump technology would have prevented an observed error was based on our current knowledge of how this technology functions. Our knowledge about the benefits and limitations of this technology will continue to evolve, as more information becomes available

Conclusions The actual number of discrepancies associated with IV infusion devices exceeds the number reported through incident reports 7 more errors were observed in one day than were reported through incident reports in two years IV medication errors associated with infusion pumps occur frequently, have the potential to cause harm and are epidemiologically diverse 16 (4%) of the discrepancies identified had the potential to cause harm The extent and nature of these errors remains mostly unknown due to the lack of research Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of medication errors:implications for infusion pump technology. Qual Saf Health Care 2005;14:80-6.

Conclusions Rate deviation errors occur and have the potential to cause harm. Pumps equipped with software that checks programmed doses against preset limits specific to a drug and clinical location can decrease the likelihood of a small number of these medication errors. 37 (9%) of the 426 observed medications were programming discrepancies and 8 (21%) had the potential to cause harm Smart pumps with dose error reduction systems will have limited impact on patient safety unless they are fully integrated with information systems such as electronic medical record (EMR), computerized prescriber order entry(cpoe), bar-coded medication administration (BCMA), and the pharmacy information system (PIS) 97.3% of rate deviation errors were rated unlikely to be prevented by smart pump technology and only 0.003% of errors overall would have been prevented by smart pump technology without an interface to other systems Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of medication errors:implications for infusion pump technology. Qual Saf Health Care 2005;14:80-6.

Were the conclusions correct?

Side-by-side comparison of results from 3 point-prevalence studies No DERS, No CPOE (2004) No DERS, CPOE (2006) DERS, CPOE (2007) Total Infusions Observed 426 461 450 Total Patients 286 294 266 Rate deviation error 37 42 33 Unauthorized error 68 32 62 Patient Identification error 55 3 2 Incorrect medication error 14 8 6 Delay of rate or medication change 4 1 3 Harm D 8 na 13 Harm E 5 na 3 Harm F 1 na 0

Percent utilization Guardrails utilization 100.00% 80.00% 60.00% 40.00% 20.00% 0.00% Guardrails Utilization by Profile and by Month Anesthesia Critical Care/ED Hematology/Oncology Labor and Delivery Med/ Surg Neonate <2kg Profile Neonate > 2kg Prentice 14 Jul-07 Aug-07 Sep-07 Oct-07 Nov-07 Dec-07 Jan-08

Consequences of alert fatigue and invalid alerts Clinicians are inundated with alerts of low or no clinical significance, leading to alert fatigue, high overrides rates and the potential to override even important alerts Profile Drug Name and Therapy Programmed Dose Rate Log Time Action Taken Patient Id Critical Care/ED fentanyl CONTINUOUS, 9990 mcg/h 999 ml/h 7/11/2007 3:38:53 Override 93721892 " fentanyl CONTINUOUS, 9990 mcg/h 999 ml/h 7/11/2007 3:38:55 93721892 " fentanyl CONTINUOUS, 150 mcg/h 15 ml/h 7/11/2007 3:39:19 93721892 Critical Care/ED fentanyl CONTINUOUS, 9990 mcg/h 999 ml/h 7/11/2007 3:42:13 Override 93721892 " fentanyl CONTINUOUS, 9990 mcg/h 999 ml/h 7/11/2007 3:42:15 93721892 Critical Care/ED fentanyl CONTINUOUS, 2000 mcg/h 200 ml/h 7/11/2007 3:42:47 Override 93721892 " fentanyl CONTINUOUS, 2000 mcg/h 200 ml/h 7/11/2007 3:42:48 93721892

What s in the literature? Alert fatigue as it pertains to Computerized Physician Order Entry (CPOE) Heish et al found 80% of allergy alerts were overridden in 1150 patients 1 At VA Puget Sound, Payne et al reports 69% of critical drug interactions were overridden and 88% of allergy-drug interaction alerts are overridden 2 At Beth Israel Deaconess Medical Center, Weingart et al, reports that physicians overrode allergy-drug alerts at a rate of 91.2% and highseverity drug-drug interactions at a rate of 89.4% 3 1 Hsieh TC, K. G., Jaggi T, Hojnowski-Diaz P, Fiskio J, Williams DH, Bates DW,Gandhi TK. (2004). Characteristics and Consequences of Drug Allergy Alert Overrides in a Computerized Physician Order Entry System. J Am Med Inform Assoc, 11, 482-491. 2 Payne TH, N. W., Hoey P. (2002). Characteristics and override rates of order checks in a practitioner order entry system. Proc AMIA Symp, 602-606. 3 Weingart, S. N., Toth, M., Sands, D. Z., Aronson, M. D., Davis, R. B., & Phillips, R.S. (2003). Physicians' Decisions to Override Computerized Drug Alerts in Primary Care. Arch Intern Med, 163(21), 2625-2631.

What s in the literature about harm related to overrides? Heish et al also found that about 1 in 20 drug-allergy overrides resulted in a significant adverse drug event (ADE) Hsieh TC, K. G., Jaggi T, Hojnowski-Diaz P, Fiskio J, Williams DH, Bates DW,Gandhi TK. (2004). Characteristics and Consequences of Drug Allergy Alert Overrides in a Computerized Physician Order Entry System. J Am Med Inform Assoc, 11, 482-491.

percent Seconds to overriding an alert n=21,394 100% 80% 60% 40% 20% 0% 76% 14% 6% 4% percent 1-2 seconds 3-5 seconds 6-10 seconds >10 seconds

Conclusions More research is needed to understand ideal use of decision support Any stand alone system or device will fail to have maximum impact on patient safety and staff satisfaction without appropriate integration between systems